Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells
Saloni Malla(University of Toledo), Amit K. Tiwari(University of Arkansas for Medical Sciences)
Cited by 3
Related Papers
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Polyamide/Poly(Amino Acid) Polymers for Drug Delivery
|Journal of Functional Biomaterials|2021|65
A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells
|Cancers|2021|20